Gholamreza Anani Sarab (Gholamreza Anani-Sarab)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Inflammatory Response

Acute Lymphoblastic Leukemia

Cell Proliferation

Top Venues

Nutritional neuroscience

Molecular biology reports

Hematology (Amsterdam, Netherlands)

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Amirhossein Rastgar, Mahtab Sayadi, Gholamreza Anani Sarab, Seyed Mehdi Sajjadi
Astaxanthin decreases the growth-inhibitory dose of cytarabine and inflammatory response in the acute lymphoblastic leukemia cell line NALM-6. Molecular biology reports 49 (7) (2022)
Leila Mobasheri, Mohsen Khorashadizadeh, Hossein Safarpour, Maryam Mohammadi, Gholamreza Anani Sarab, Vahid Reza Askari
Anti-Inflammatory Activity of Ferula assafoetida Oleo-Gum-Resin (Asafoetida) against TNF- α -Stimulated Human Umbilical Vein Endothelial Cells (HUVECs). Mediators of inflammation 2022 (2022)
Hamidreza Safari, Gholamreza Anani Sarab, Mohsen Naseri
Artemisia dracunculus L. modulates the immune system in a multiple sclerosis mouse model. Nutritional neuroscience 24 (11) (2019)
Abdolghader Taene, Ghazaleh Khalili-Tanha, Aliakbar Esmaeili, Leila Mobasheri, Omid Kooshkaki, Somaieh Jafari, Alireza Shokouhifar, Gholamreza Anani Sarab
The Association of Major Depressive Disorder with Activation of NLRP3 Inflammasome, Lipid Peroxidation, and Total Antioxidant Capacity. Journal of molecular neuroscience : MN 70 (1) (2019)
Bahman Razi, Gholamreza Anani Sarab, Azadeh Omidkhoda, Shahab Alizadeh
Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C > T) and susceptibility to multiple myeloma: a systematic review and meta-analysis. Hematology (Amsterdam, Netherlands) 23 (8) (2018)